%0 Review
%T HSR24-152: Patient-Reported Outcome (PRO) Data in Oncology NDAs Approved by the FDA (2018-2021): A Review of Criticism and Concerns in Comments From Regulators.
%A Comerford E
%A Norcross L
%A Sasane M
%A Zheng Y
%A Gnanasakthy A
%J J Natl Compr Canc Netw
%V 22
%N 2
%D 2024 Apr 5
%M 38580230
%F 12.693
%R 10.6004/jnccn.2023.7146